Literature DB >> 27558529

Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection.

Honggang Xia1, Zhongyi Sun1, Limin Deng1, Deqing Zhu1, Dongbin Wang1.   

Abstract

In this study, we investigated the correlation between lymphocyte to monocyte ratio (LMR) and clinical outcomes in stage I non-small cell lung cancer (NSCLC) patients. A total of 439 stage I NSCLC patients were enrolled in this study. Multivariate analyses identified LMR as an independent prognostic factor for recurrence-free survival and overall survival (hazard ratio (HR: 0.469, 95% Confidence Interval (CI): 0.325-0.677, and p < 0.001, and HR: 0.478, 95% CI: 0.332-0.688, and p < 0.001; respectively). Compared with the high LMR group, the proportion of patients who developed distant metastasis was significantly higher in the low LMR group.

Entities:  

Keywords:  Lymphocyte to monocyte ratio; non-small cell lung cancer; prognosis

Mesh：

Year:  2016        PMID： 27558529     DOI： 10.1080/07357907.2016.1213276

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


  14 in total

1.  Long-term outcomes of video-assisted thoracoscopic surgery lobectomy vs. thoracotomy lobectomy for stage IA non-small cell lung cancer.

Authors:  Risa Oda; Katsuhiro Okuda; Satoshi Osaga; Takuya Watanabe; Tadashi Sakane; Tsutomu Tatematsu; Keisuke Yokota; Hiroshi Haneda; Ryoichi Nakanishi
Journal:  Surg Today       Date:  2018-12-03       Impact factor: 2.549

2.  Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis.

Authors:  Apostolos Gaitanidis; Dhaval Patel; Naris Nilubol; Amit Tirosh; Samira Sadowski; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2017-11-13       Impact factor: 5.344

3.  Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinoma.

Authors:  Apostolos Gaitanidis; Douglas Wiseman; Mustapha El Lakis; Naris Nilubol; Electron Kebebew; Dhaval Patel
Journal:  J Surg Oncol       Date:  2019-11-16       Impact factor: 2.885

4.  Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer.

Authors:  Wei Liu; Minwen Ha; Nanchang Yin
Journal:  Oncotarget       Date:  2017-06-01

5.  Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.

Authors:  Wen Li; Guangzhi Ma; Qiang Wu; Yunfu Deng; Ya Liu; Jing Wang
Journal:  Oncotarget       Date:  2017-08-28

6.  Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.

Authors:  Yongqiang Chen; Weidong Wang; Xuewen Zhang; Xiangyang Yu; Kexing Xi; Yingsheng Wen; Gongming Wang; Xiaoli Feng; Lanjun Zhang
Journal:  Cancer Manag Res       Date:  2018-11-08       Impact factor: 3.989

7.  Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis.

Authors:  Yi Zhang; Bo Chen; Lijuan Wang; Rong Wang; Xianjin Yang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

8.  Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.

Authors:  Jialin Li; Yusheng Cheng; Zhigang Ji
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

9.  A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio.

Authors:  Jiani Gao; Yijiu Ren; Haoyue Guo; Rui Mao; Huikang Xie; Hang Su; Yunlang She; Jiajun Deng; Minglei Yang; Biao Han; Yu Zhang; Jian Li; Dong Xie; Chang Chen
Journal:  Ann Transl Med       Date:  2020-04

10.  Preoperative lymphocyte-to-monocyte ratio as a strong predictor of survival and recurrence for gastric cancer after radical-intent surgery.

Authors:  Jun-Peng Lin; Jian-Xian Lin; Long-Long Cao; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Mi Lin; Ru-Hong Tu; Chang-Ming Huang
Journal:  Oncotarget       Date:  2017-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.